Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Praxis Precision Medicines Inc (NASDAQ: PRAX) closed at $37.11 in the last session, up 3.46% from day before closing price of $35.87. In other words, the price has increased by $3.46 from its previous closing price. On the day, 0.44 million shares were traded. PRAX stock price reached its highest trading level at $37.91 during the session, while it also had its lowest trading level at $34.69.
Ratios:
We take a closer look at PRAX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.77 and its Current Ratio is at 10.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 03, 2025, Reiterated its Buy rating but revised its target price to $105 from $120 previously.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $111.
On August 05, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $134.Oppenheimer initiated its Outperform rating on August 05, 2024, with a $134 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 14 ’24 when Nemiroff Alex sold 8,239 shares for $80.20 per share. The transaction valued at 660,827 led to the insider holds 10,301 shares of the business.
Mastrocola Lauren sold 5,188 shares of PRAX for $424,318 on Nov 14 ’24. The Principal Accounting Officer now owns 5,613 shares after completing the transaction at $81.78 per share. On Nov 14 ’24, another insider, Mastrocola Lauren, who serves as the Officer of the company, bought 5,189 shares for $81.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 748256384 and an Enterprise Value of 332057792. For the stock, the TTM Price-to-Sale (P/S) ratio is 87.52 while its Price-to-Book (P/B) ratio in mrq is 1.62. Its current Enterprise Value per Revenue stands at 38.824 whereas that against EBITDA is -1.662.
Stock Price History:
The Beta on a monthly basis for PRAX is 2.68, which has changed by -0.26862437 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, PRAX has reached a high of $91.83, while it has fallen to a 52-week low of $30.01. The 50-Day Moving Average of the stock is -37.07%, while the 200-Day Moving Average is calculated to be -39.68%.
Shares Statistics:
According to the various share statistics, PRAX traded on average about 492.70K shares per day over the past 3-months and 494050 shares per day over the past 10 days. A total of 19.42M shares are outstanding, with a floating share count of 18.74M. Insiders hold about 7.07% of the company’s shares, while institutions hold 105.76% stake in the company. Shares short for PRAX as of 1741910400 were 2060595 with a Short Ratio of 4.18, compared to 1739491200 on 2668966. Therefore, it implies a Short% of Shares Outstanding of 2060595 and a Short% of Float of 10.229999600000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
